BioLife Solutions: Powering the Preservation Sciences
BioLife Solutions has a strong interest in target markets: regenerative medicine, biobanking, and drug discovery.
regenerative medicine
NeoStem Discovering the Power of Stem Cell Technology in Wound Care
Preliminary data in preclinical models of severe complex wounds suggests that human VSELs™ (very small embryonic like stem cells) accelerates wound healing. NeoStem hopes to advance into early clinical studies to assess therapeutic potential of VSEL technology.
ISTO’s Cell Therapies Can Revolutionize Treatment of Joint, Bone Injuries
ISTO Technologies, Inc.is both a regenerative medicine and orthopedics company developing innovative cartilage and bone regeneration products for spinal therapy, sports medicine and trauma. ISTO is currently focused on the development of cell-based cartilage platform technology that can be applied to repair and regenerate damaged cartilage in the knee and spinal disc.
ISTO Technologies CFO: No Other Company Can Grow Living Cartilage in a Lab Setting
ISTO Technologies has a unique pipeline that has demonstrated both clinical progress and market success. With one commercialized product — a bone graft extender and substitute — and two late-stage clinical programs focusing in engineering cartilage tissue for knee and back, respectively, the company is poised to capture an opportunistic yet untapped market. OneMedRadio spoke with CFO Scott Gill about market opportunity, and finding success in a notoriously unfriendly space.
OneMedRadio: Intellicell BioSciences CEO Talks Stromal Vascular Cells
Intellicell BioSciences (OTC: SVFC) has pioneered a unique method of acquiring stromal vascular fraction cells derived from the blood vessels in the adult adipose tissue. The company’s proprietary protocol can separate adult autologous VFC cells from the adipose tissue without the use of enzymes.
Jason Napodano Discusses the “Buzz Word” Regenerative Medicine and Why its a Hot Area in Biotech
Napodano, a senior biotech analyst for Zacks Investment Research discusses 4 regenerative medicine companies making headway in the space.
Sector Reports on Investment Opportunities in Health and Medicine Featured at 5th Annual OneMedForum
OneMedPlace announced today that OneMedForum San Francisco 2012 will feature special reports in 8 healthcare sectors.
Soft Tissue Regeneration Advancing Next-Generation Device for Common Sports Injury
The cruciate ligaments of the knee are vital for a wide range of activities, from bending over to pick up something on the ground to running bases at a softball game.
Cytori Therepeutics Featured in Wired Magazine
Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
Growing Regenerative Medicine Market Provides Opportunities for Cytori Therapeutics
For many breast cancer patients, the effects of undergoing a mastectomy go well beyond the physical.